When the smoking cessation medication, Chantix, was trending on Twitter Monday, it quickly became apparent that it wasn’t just because the manufacturer had recalled it. Yes, the recall of the drug ...

New government-approved labeling on Pfizer's drug Chantix suggests that the anti-smoking medication may not carry the risks of suicidal behavior that first earned it the Food and Drug Administration's ...

NEW YORK (Reuters Health) - In a trial among people with a history of depression, those taking the quit-smoking aid varenicline - marketed in the U.S. as Chantix - were no more prone to depression or ...

A popular drug prescribed to help people quit smoking may pose a significantly increased risk of heart attack in users, a new study finds. The results may further complicate doctors’ and patients’ ...

The U.S. Food and Drug Administration announced Friday it will convene a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer's anti-smoking drug ...

Law360 (July 15, 2020, 10:34 PM EDT) -- Pfizer Inc. must face claims that it failed to properly monitor smoking-cessation drug Chantix for potential side effects like severe muscle disorders, spasms ...

The Food and Drug Administration has been investigating reports of mood disorders and erratic behavior among Chantix patients since 2007. The agency said in a statement that two federally-funded ...

Please provide your email address to receive an email when new articles are posted on . Pfizer has voluntarily expanded its recall of Chantix 0.5 mg and 1 mg tablets because of the presence of the ...

Pfizer, Glaxo hope FDA will remove warning on their smoking-cessation pills, after big study finds no suicide risk This April 13, 2016, photo provided by Pfizer shows Pfizer Discovery Medicinal ...

Pfizer has received a jolt on the publication of a study which claims that the firm’s smoking cessation product Chantix has been linked to more than 3,000 reports of adverse events including ...

Pfizer's stop-smoking drug Chantix can lead to a small increase in cardiovascular problems such as heart attacks for patients who already have cardiovascular disease, U.S. drug regulators said on ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...